Moxifloxacin hydrochlorideMeSH concept

http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/izilox_14032012_avis_ct11809.pdf
http://www.has-sante.fr/portail/jcms/c_468673/izilox
http://www.has-sante.fr/portail/jcms/c_399295/izilox-400-mg-comprime-pellicule-boites-5-7-50
http://www.has-sante.fr/portail/jcms/c_1234504/izilox
2012
France
French
antibiotic therapy
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
moxifloxacin hydrochloride
adult
sinusitis
acute disease
bronchitis, chronic
bronchitis, chronic
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug)
community-acquired infections
pneumonia, bacterial
aza compounds
quinolines
moxifloxacin
anti-bacterial agents
Moxifloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67730483
2012
France
summary of product characteristics
package leaflet
tablets
moxifloxacin hydrochloride
Moxifloxacin

---
http://www.has-sante.fr/portail/jcms/c_1234498/octegra
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/octegra_14032012_avis_ct_10703.pdf
2012
France
French
antibiotic therapy
administration, oral
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug)
moxifloxacin
insurance, health, reimbursement
moxifloxacin hydrochloride
anti-bacterial agents
adult
sinusitis
acute disease
bronchitis, chronic
bronchitis, chronic
community-acquired infections
pneumonia, bacterial
aza compounds
quinolines
evaluation of the transparency committee
Moxifloxacin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62419261
2012
France
summary of product characteristics
package leaflet
moxifloxacin hydrochloride
Moxifloxacin

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-08/izilox_iv_-_ct-8141.pdf
http://www.has-sante.fr/portail/jcms/c_997039/izilox-iv-moxifloxacine-fluoroquinolone-par-voie-intraveineuse
2010
France
French
antibiotic therapy
anti-bacterial agents
infusions, intravenous
quinolines
aza compounds
moxifloxacin
quinolines
treatment outcome
anti-bacterial agents
aza compounds
Moxifloxacin hydrochloride 1.6mg/mL infusion solution 250mL bag (product)
moxifloxacin hydrochloride
moxifloxacin hydrochloride
guidelines for drug use
evaluation of the transparency committee
Moxifloxacin
Moxifloxacin

---
http://www.has-sante.fr/portail/jcms/c_973830/izilox
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-08/izilox_iv_-_ct-8141.pdf
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/izilox_ct_8141.pdf
2010
France
French
English
antibiotic therapy
Moxifloxacin hydrochloride 1.6mg/mL infusion solution 250mL bag (product)
moxifloxacin
infusions, intravenous
aza compounds
quinolines
anti-bacterial agents
community-acquired infections
pneumonia
skin diseases, infectious
soft tissue infections
treatment outcome
moxifloxacin hydrochloride
evaluation of the transparency committee
Moxifloxacin

---